DILAFOR AB has a total of 82 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Canada, Australia and China. Its main competitors in its focus markets pharmaceuticals and macromolecular chemistry and polymers are YEDGAR SAUL, EURAND PHARMACEUTICALS LTD and TINNITUS FORSCHUNGS UND ENTWIC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 7 | |
#2 | Australia | 6 | |
#3 | China | 6 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | Hong Kong | 6 | |
#6 | Israel | 6 | |
#7 | United States | 6 | |
#8 | Mexico | 5 | |
#9 | WIPO (World Intellectual Property Organization) | 5 | |
#10 | South Africa | 4 | |
#11 | New Zealand | 3 | |
#12 | Singapore | 3 | |
#13 | Ukraine | 3 | |
#14 | Brazil | 2 | |
#15 | Hungary | 2 | |
#16 | Chile | 1 | |
#17 | Colombia | 1 | |
#18 | United Kingdom | 1 | |
#19 | Japan | 1 | |
#20 | Republic of Korea | 1 | |
#21 | Montenegro | 1 | |
#22 | Norway | 1 | |
#23 | Poland | 1 | |
#24 | Serbia | 1 | |
#25 | Russian Federation | 1 | |
#26 | Sweden | 1 | |
#27 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Ekman-Ordeberg Gunvor | 43 |
#2 | Eriksson Per-Olov | 20 |
#3 | Holmer Erik | 15 |
#4 | Lindahl Ulf | 13 |
#5 | Malmstrom Anders | 13 |
#6 | Ekre Hans-Peter | 12 |
#7 | Malmström Anders | 12 |
#8 | Malmstroem Anders | 9 |
#9 | Holmer Erik Yngve | 7 |
#10 | Malmström Anders Malmström | 4 |
Publication | Filing date | Title |
---|---|---|
GB201310928D0 | New Processes | |
CA2868403A1 | Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent | |
US2015045322A1 | Combination treatment comprising sulphated glycosaminoglycans for inducing labor | |
EP2830634A1 | Method for treatment of labor arrest | |
US2015011505A1 | Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use | |
MX2012006966A | Treatment of cytokine mediated conditions. | |
AU2012203519A1 | Treatment of cytokine mediated conditions | |
CA2779838A1 | Treatment of cytokine mediated conditions | |
CN1612741A | Use of sulfated glycosaminoglycans for establishing effective labor in women |